Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ontario Clinical Oncology Group (OCOG)
Age
0–75
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
All patients must have histologically proven adenocarcinoma of the prostate
The primary tumour should be staged clinically B2 or C as classified by A.J.C. Staging System
You may not be if
Patients requiring transurethral prostatectomy (TURP) prior to diagnosis
Presence of metastases identified by bone scan, chest x-ray or CT scan of the abdomen and pelvis, or staging lymphadenectomy
Karnofsky performance status less than 80
Inadequate laboratory results: i.e. Hb \< 12 gm/litre, WBC \< 3.5 x 10 per litre, platelets \< 100 x 10/litre, urea \> 13 mmol/litre, creatinine \> 220 mmol/litre
Unfit for surgery for other medical reasons
Age above 75 years
Failure to provide written informed consent
Clareo Health | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate
